David Baran, MD

Appointed
2022

Education & Fellowships

Fellowship - New York Presbyterian Hospital, Columbia Presbyterian Campus
Heart Transplant Fellowship
New York, NY USA
1999

Fellowship - Icahn School of Medicine at Mount Sinai
Cardiovascular Diseases
New York, NY USA
1998

Residency - New York Presbyterian Hospital, Columbia Presbyterian Campus
Internal Medicine
New York, NY USA
1995

Medical Education - University of South Florida Morsani College of Medicine
Tampa, FL USA
1992

Professional Highlights

• Section Head, Heart Failure, Transplant and MCS, Cleveland Clinic Florida
• Led team establishing SCAI Shock Staging which is used worldwide
• Prospective trial of reduced immunosuppression in adult heart transplant recipients

Certifications

• Internal Medicine - Advanced Heart Failure and Transplant Cardiology
• Internal Medicine - Cardiovascular Disease

Awards & Honors

• University Scholar, College of Natural Science, Florida Atlantic University 1988

  - Award for outstanding scholarship in the class of 1988, College of Natural Science.

  Infectious Diseases Special Contribution, Tampa General Hospital, May 1992

  - Designed ID consult database for the Department, to allow tracking of patients seen in consult, allowing trend analysis, and data collection for potential research projects.

  Letter of Commendation, Department of Medicine, Presbyterian Hospital 1993

  - Outstanding medical student teaching, based on confidential student evaluations.

  Elected to Fellowship, American College of Cardiology, 2000

  Mt. Sinai Hospital Team Excellence Award, 2001

  - Overall excellence of cardiac transplant team, shared by all members

  Mentor, Fellow recipient of Abstract Travel Award. Transplant Summit 2005: Defining the Future. San Francisco, October 26-28, 2005.

  Mentor, Fellow recipient of Abstract Travel Award. Transplant Summit 2007: Defining the Future. Chicago, October 23-25, 2007.

  Mentor, Fellow recipients of Travel Grant Award. AST Fellow in Transplant Training Seminar, Grapevine, Texas, Oct 2009

  Mentor, Fellow recipients of Travel Grant Award. AST Fellow in Transplant Training Seminar, Grapevine, Texas, Oct 2010

  Mentor, Fellow recipients of Travel Grant Award. AST Fellow in Transplant Training Seminar, Grapevine, Texas, Oct 2011

  Mentor, Fellow recipients of Travel Grant Award. AST Fellow in Transplant Training Seminar, Grapevine, Texas, Oct 2012

  Mentor, Fellow recipients of Travel Grant Award. AST Fellow in Transplant Training Seminar, Grapevine, Texas, Oct 2013

  Elected to Fellowship, Society for Cardiac Angiography and Intervention, May 2014

  Elected to Fellowship, Heart Failure Society of America, May 2019

  “Top Doc”, Coastal Virginia Magazine 2019-2020 (Cardiology division)

Memberships

• Name of Society American College of Cardiology

  Role / Title Fellow of the American College of Cardiology

  Start-End Dates 1997- Present

  Name of Society American Heart Association

  Role / Title Member, Clinical Cardiology Council

  Start-End Dates 1997- Present

  Name of Society International Society for Heart and Lung Transplantation

  Role / Title Member

  Start-End Dates 1998- Present

  Name of Society American Society of Transplantation

  Role / Title Member, former Executive Council Chair

  Start-End Dates 2006- Present

  Name of Society Heart Failure Society of America

  Role / Title Fellow of the Heart Failure Society of America

  Start-End Dates 2010- Present

  Name of Society Society for Cardiac Angiography and Intervention

  Role / Title Fellow of the Society for Cardiac Angiography and Intervention

  Start-End Dates 2014- Present

  Name of Society Extracorporeal Life Support Organization

  Role / Title Member

  Start-End Dates 2019- Present

See publications for David Baran, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/5/2023, Dr. Baran has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.